Five Oceans Advisors Astrazeneca PLC Transaction History
Five Oceans Advisors
- $221 Million
- Q3 2025
A detailed history of Five Oceans Advisors transactions in Astrazeneca PLC stock. As of the latest transaction made, Five Oceans Advisors holds 7,994 shares of AZN stock, worth $714,663. This represents 0.28% of its overall portfolio holdings.
Number of Shares
7,994
Previous 7,592
5.3%
Holding current value
$714,663
Previous $530,000
15.66%
% of portfolio
0.28%
Previous 0.26%
Shares
12 transactions
Others Institutions Holding AZN
# of Institutions
1,510Shares Held
501MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...